Report on the risk of risk of cardiac ischaemia in CCS
Report on cumulative incidence of symptomatic cardiac ischaemia and its risk factors among European 5-year childhood cancer survivors.
The article concludes that by age 60 years, 1 in 18 CCS will develop a severe, life-threatening or fatal cardiac ischaemia, especially in lymphoma survivors and CCS treated with radiotherapy and chemotherapy increases the risk significantly.
Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.
Be the first to share your thoughts!
Article on the aim and importance of the PanCareSurFup project
Evaljuation of subsequent primary malignancies, cardiac disease and late mortality in survivors and guideline developmen...
This study critically evaluates and summarises the latest evidence on the QoL of childhood cancer survivors in Europe an...
